NCT01644994View on ClinicalTrials.gov

Intracavitary Cisplatin-Fibrin Localized Chemotherapy After P/D or EPP for Malignant Pleural Mesothelioma

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

December 31, 2019

Study Completion Date

August 31, 2021

Conditions
Malignant Pleural Mesothelioma
Interventions
COMBINATION_PRODUCT

intracavitary cisplatin-fibrin

single dose, local intracavitary application of cisplatin-fibrin after pleurectomy/decortication

Trial Locations (1)

8091

University Hospital Zurich, Division of Thoracic Surgery, Zurich

All Listed Sponsors
collaborator

Swiss National Science Foundation

OTHER

collaborator

Swiss Accident Insurance Fund SUVA

UNKNOWN

lead

University of Zurich

OTHER

NCT01644994 - Intracavitary Cisplatin-Fibrin Localized Chemotherapy After P/D or EPP for Malignant Pleural Mesothelioma | Biotech Hunter | Biotech Hunter